Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 2Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Radiotherapy 6Cisplatin 3Amifostine 3Magnetic Resonance Spectroscopy 2Etoposide 2sargramostim 1Serotonin Plasma Membrane Transport Proteins 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Pentetic Acid 1Paclitaxel 1Mental Status and Dementia Tests 1Ifosfamide 1Hyperbaric Oxygenation 1Filgrastim 1Fibroblast Growth Factor 7 1Early Intervention, Educational 1Diet Therapy 1Dexamethasone 1Daclizumab 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Radiation Injuries × Pentetic Acid × Clear all
NCT00019227 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
LymphoidOther hematologic neoplasm

Lymphoma, Radiation Injuries, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡